SUBSCRIBE
SUBSCRIBE

Genentech, Inc.

NEWS
BioCapital
Genentech’s Drug-Laser Combination Proves Effective For Diabetic Blindness, Johns Hopkins University Study
April 28, 2010
 · 
1 min read
Policy
Biotechs, VCs Shoot, Score with Reform; Legislation Gives Brand Name Drug Developers Like Genentech (South SF) And Amgen 12 Years of Data Exclusivity
March 23, 2010
 · 
1 min read
Genentech Splashes into 2010 with Positive Job Growth Expectations: Exclusive Interview with Talent Acquisition Leader
Job Trends
Genentech Splashes into 2010 with Positive Job Growth Expectations: Exclusive Interview with Talent Acquisition Leader
March 22, 2010
 · 
4 min read
Bookmark and Share
Biotech Bay
Genentech (South SF) Puts Words In The Mouths Of Politicians
November 17, 2009
 · 
1 min read
Bookmark and Share
BioMidwest
Genentech, Inc.'s Hedgehog Drug Helps Late-Stage Cancers, Johns Hopkins University, Karmanos Cancer Institute And Translational Genomics Research Institute (TGen) Study
September 3, 2009
 · 
1 min read
Deals
Genentech, Inc.'s Levinson May Have No Change-of-Control Agreement in Roche Deal
March 13, 2009
 · 
1 min read
Biogen Idec, Inc. (California) And Genentech, Inc.'s Rituxan Can Cut Kidney Inflammation In Lupus, Imperial College London Study
March 5, 2009
 · 
1 min read
Biotech Bay
Another Possible Alzheimer’s Culprit Found, Genentech, Inc. And Salk Institute for Biological Studies Study
February 19, 2009
 · 
1 min read
Drug Development
Genentech, Inc. And Biogen Idec, Inc. (California)'s Rituximab Maintenance Therapy Improves Survival In Patients With Relapsed Follicular Lymphoma, Rabin Medical Center (Beilinson Hospital) Study
February 11, 2009
 · 
1 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Press Releases
FDA Approves Genentech’s Lunsumio VELO™ for Subcutaneous Use in Relapsed or Refractory Follicular Lymphoma
December 22, 2025
 · 
16 min read
Press Releases
Genentech Announces Agreement With U.S. Government
December 22, 2025
 · 
2 min read
Press Releases
Roche announces U.S. launch of next-generation cobas 6800/8800 systems and software, enhancing laboratory efficiency and testing capabilities
December 17, 2025
 · 
3 min read
Press Releases
Caris Life Sciences Announces Collaboration with Genentech to Discover Novel Therapeutic Targets in Cancers with High Unmet Clinical Need
December 17, 2025
 · 
6 min read
Press Releases
Genentech’s Giredestrant Reduced Risk of Invasive Disease Recurrence or Death by 30% in ER-positive Early-Stage Breast Cancer
December 11, 2025
 · 
7 min read
Press Releases
Roche’s giredestrant reduced risk of invasive disease recurrence or death by 30% in ER-positive early-stage breast cancer
December 10, 2025
 · 
13 min read
Press Releases
Genentech Presents Lunsumio Data Showing Potential Across Earlier Treatment Lines in Indolent and Aggressive Lymphomas
December 9, 2025
 · 
19 min read
Press Releases
KaliVir Immunotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate VET3-TGI in Combination with Atezolizumab (Tecentriq®) in Advanced Solid Tumors
November 20, 2025
 · 
2 min read
Press Releases
European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphoma
November 19, 2025
 · 
8 min read
Press Releases
Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers
November 19, 2025
 · 
7 min read
Load More